Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Pilot Study of Long-Acting Injectable Naltrexone Treatment for Cannabis Dependence

NCT02088177 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT02088177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02088177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Pilot Study of Long-Acting Injectable Naltrexone Treatment for Cannabis Dependence
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2014
Completion date
March 31, 2016
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis dependence